Terms: = Breast cancer AND GOPC, FIG, 57120, ENSG00000047932, GOPC1, Q9HD26, CAL, dJ94G16_2 PIST AND Prognosis
19 results:
1. Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis.
Smoots SG; Schreiber AR; Jackson MM; Bagby SM; Dominguez ATA; Dus ED; Binns CA; MacBeth M; Whitty PA; Diamond JR; Pitts TM
Breast Cancer Res; 2024 Mar; 26(1):35. PubMed ID: 38429789
[TBL] [Abstract] [Full Text] [Related]
2. Intraoperative evaluation of metastases in sentinel nodes through one-step nucleic acid amplification: Initial experience in a single institution.
Pohlodek K; Feriancova M; Kotvanova K; Meciarova I
Bratisl Lek Listy; 2023; 124(3):163-169. PubMed ID: 36598305
[TBL] [Abstract] [Full Text] [Related]
3. Systematic screening identifies a TEAD4-S100A13 axis modulating cisplatin sensitivity of oral squamous cell carcinoma cells.
Li R; Li W; He F; Zhang M; Luo H; Tang H
J Oral Pathol Med; 2021 Oct; 50(9):882-890. PubMed ID: 34358353
[TBL] [Abstract] [Full Text] [Related]
4. The value of maspin and PD-L1 expression and peritumoral lymphocytic infiltration in breast tumors.
Tuncel F; Bozkurt F; Berkesoglu M
Bratisl Lek Listy; 2020; 121(12):894-900. PubMed ID: 33300360
[TBL] [Abstract] [Full Text] [Related]
5. Chrysosplenol d, a Flavonol from
Lang SJ; Schmiech M; Hafner S; Paetz C; Werner K; El Gaafary M; Schmidt CQ; Syrovets T; Simmet T
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32521698
[TBL] [Abstract] [Full Text] [Related]
6. Inclusion of hnRNP L Alternative Exon 7 Is Associated with Good prognosis and Inhibited by Oncogene SRSF3 in Head and Neck Squamous Cell Carcinoma.
Xu L; Shen J; Jia J; Jia R
Biomed Res Int; 2019; 2019():9612425. PubMed ID: 31828152
[TBL] [Abstract] [Full Text] [Related]
7. Cholesterol and 27-hydroxycholesterol promote thyroid carcinoma aggressiveness.
Revilla G; Pons MP; Baila-Rueda L; García-León A; Santos D; Cenarro A; Magalhaes M; Blanco RM; Moral A; Ignacio Pérez J; Sabé G; González C; Fuste V; Lerma E; Faria MDS; de Leiva A; Corcoy R; Carles Escolà-Gil J; Mato E
Sci Rep; 2019 Jul; 9(1):10260. PubMed ID: 31311983
[TBL] [Abstract] [Full Text] [Related]
8. The role of kisspeptin on aromatase expression in breast cancer.
Yilmaz MB; Oksuz H; Ilgaz NS; Ocal I; Tazehkand MN
Bratisl Lek Listy; 2018; 119(12):776-780. PubMed ID: 30686017
[TBL] [Abstract] [Full Text] [Related]
9. Factors affecting sentinel lymph node metastasis in Turkish breast cancer patients: Predictive value of Ki-67 and the size of lymph node.
Ozemir IA; Orhun K; Eren T; Baysal H; Sagiroglu J; Leblebici M; Ceyran AB; Alimoglu O
Bratisl Lek Listy; 2016; 117(8):436-41. PubMed ID: 27546694
[TBL] [Abstract] [Full Text] [Related]
10. A comparison of Ki 67 proliferative index in primary tumor and axillary metastatic lymph nodes with length of survival in patients with breast cancer.
Paksoy SE; Tasdelen I; Balaban AS; Ozkaya G; Tolunay S
Bratisl Lek Listy; 2013; 114(11):645-9. PubMed ID: 24236435
[TBL] [Abstract] [Full Text] [Related]
11. Adrenal metastases.
Wagnerova H; Lazurova I; Felsoci M
Bratisl Lek Listy; 2013; 114(4):237-40. PubMed ID: 23514559
[TBL] [Abstract] [Full Text] [Related]
12. Aggressive treatment for hepatic metastases from breast cancer: results from a single center.
Polistina F; Costantin G; Febbraro A; Robusto E; Ambrosino G
World J Surg; 2013 Jun; 37(6):1322-32. PubMed ID: 23474856
[TBL] [Abstract] [Full Text] [Related]
13. Spheroid assay to measure TGF-β-induced invasion.
Naber HP; Wiercinska E; Ten Dijke P; van Laar T
J Vis Exp; 2011 Nov; (57):. PubMed ID: 22126971
[TBL] [Abstract] [Full Text] [Related]
14. Consequences of abdominal adenocarcinoma in post-menopausal woman in relation to surgical and non-surgical management.
Moniruzzaman M; Faruquzzaman ; Mohiuddin T
Bratisl Lek Listy; 2011; 112(8):472-4. PubMed ID: 21863621
[TBL] [Abstract] [Full Text] [Related]
15. Immunohistochemical evaluation of Pi class glutathione S-transferase expression in invasive breast carcinoma.
Vecanova J; Hodorova I; Mihalik J; Benicky M; Kluchova D; Rybarova S
Bratisl Lek Listy; 2011; 112(2):67-70. PubMed ID: 21456504
[TBL] [Abstract] [Full Text] [Related]
16. The effects of E-cadherin and bcl-2 on prognosis in patients with breast cancer.
Kavgaci H; Yildiz B; Fidan E; Reis A; Ozdemir F; Cobanoglu U; Can G
Bratisl Lek Listy; 2010; 111(9):493-7. PubMed ID: 21180263
[TBL] [Abstract] [Full Text] [Related]
17. Chromatin texture, DNA index, and S-phase fraction in primary breast carcinoma cells analysed by laserscanning cytometry.
Kuliffay P; Sanislo L; Galbavy S
Bratisl Lek Listy; 2010; 111(1):4-8. PubMed ID: 20429304
[TBL] [Abstract] [Full Text] [Related]
18. Treatment strategy of early-stage breast cancer.
Svetlovska D; Mardiak J
Bratisl Lek Listy; 2005; 106(11):362-5. PubMed ID: 16541622
[TBL] [Abstract] [Full Text] [Related]
19. The primary use of endocrine therapies.
Howell A; Anderson E; Blamey R; Clarke RB; Dixon JM; Dowsett M; Johnston SR; Miller WR; Nicholson R; Robertson JF
Recent Results Cancer Res; 1998; 152():227-44. PubMed ID: 9928561
[TBL] [Abstract] [Full Text] [Related]